[GAMUDA] YoY TTM Result on 31-Oct-2020 [#1]

Stock
[GAMUDA] GAMUDA BHD
Announcement Date
21-Dec-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Jul-2021
Quarter
31-Oct-2020 [#1]
Profit Trend
QoQ- -17.31%
YoY- -56.57%
Quarter Report
Latest QR
Upcoming QR
GAMUDA's Result
GAMUDA's Financial Summary
View:
Show?
TTM Result
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Revenue 9,731,583 5,649,000 3,500,378 3,331,089 4,757,009 4,359,119 3,478,345 18.69%
PBT 1,122,597 1,001,415 836,948 508,312 900,653 696,137 879,681 4.14%
Tax -240,718 995,060 -161,115 -149,120 -143,314 -163,108 -180,713 4.89%
NP 881,879 1,996,475 675,833 359,192 757,339 533,029 698,968 3.94%
-
NP to SH 864,775 1,822,524 631,402 307,348 707,690 482,904 642,962 5.06%
-
Tax Rate 21.44% -99.37% 19.25% 29.34% 15.91% 23.43% 20.54% -
Total Cost 8,849,704 3,652,525 2,824,545 2,971,897 3,999,670 3,826,090 2,779,377 21.28%
-
Net Worth 11,122,490 11,139,941 9,274,920 8,571,129 8,284,814 7,799,714 7,656,779 6.41%
Dividend
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Div 320,739 1,287,051 150,811 - 296,479 295,675 292,926 1.52%
Div Payout % 37.09% 70.62% 23.89% - 41.89% 61.23% 45.56% -
Equity
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Net Worth 11,122,490 11,139,941 9,274,920 8,571,129 8,284,814 7,799,714 7,656,779 6.41%
NOSH 2,698,138 2,591,069 2,513,528 2,513,527 2,473,407 2,468,264 2,455,000 1.58%
Ratio Analysis
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
NP Margin 9.06% 35.34% 19.31% 10.78% 15.92% 12.23% 20.09% -
ROE 7.78% 16.36% 6.81% 3.59% 8.54% 6.19% 8.40% -
Per Share
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
RPS 362.23 219.06 139.26 132.53 192.35 176.61 141.74 16.91%
EPS 32.19 70.68 25.12 12.23 28.62 19.56 26.20 3.48%
DPS 11.94 49.91 6.00 0.00 12.00 12.00 12.00 -0.08%
NAPS 4.14 4.32 3.69 3.41 3.35 3.16 3.12 4.82%
Adjusted Per Share Value based on latest NOSH - 2,513,527
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
RPS 342.19 198.64 123.08 117.13 167.27 153.28 122.31 18.69%
EPS 30.41 64.09 22.20 10.81 24.88 16.98 22.61 5.06%
DPS 11.28 45.26 5.30 0.00 10.43 10.40 10.30 1.52%
NAPS 3.911 3.9171 3.2613 3.0139 2.9132 2.7426 2.6924 6.41%
Price Multiplier on Financial Quarter End Date
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Date 31/10/23 31/10/22 29/10/21 30/10/20 31/10/19 31/10/18 31/10/17 -
Price 4.64 3.85 3.24 3.33 3.74 2.39 5.25 -
P/RPS 1.28 1.76 2.33 2.51 1.94 1.35 3.70 -16.20%
P/EPS 14.42 5.45 12.90 27.23 13.07 12.22 20.04 -5.33%
EY 6.94 18.36 7.75 3.67 7.65 8.19 4.99 5.64%
DY 2.57 12.96 1.85 0.00 3.21 5.02 2.29 1.94%
P/NAPS 1.12 0.89 0.88 0.98 1.12 0.76 1.68 -6.53%
Price Multiplier on Announcement Date
31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 31/10/17 CAGR
Date 06/12/23 16/12/22 21/12/21 21/12/20 13/12/19 14/12/18 15/12/17 -
Price 4.41 3.61 2.92 3.86 3.78 2.28 4.75 -
P/RPS 1.22 1.65 2.10 2.91 1.97 1.29 3.35 -15.48%
P/EPS 13.70 5.11 11.62 31.57 13.21 11.65 18.13 -4.56%
EY 7.30 19.58 8.60 3.17 7.57 8.58 5.52 4.76%
DY 2.71 13.83 2.05 0.00 3.17 5.26 2.53 1.15%
P/NAPS 1.07 0.84 0.79 1.13 1.13 0.72 1.52 -5.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment